This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Measuring Reading Rehabilitation Outcomes

This study has been completed.
Information provided by:
VA Office of Research and Development Identifier:
First received: July 28, 2005
Last updated: February 3, 2009
Last verified: December 2006
The purpose of this study is to measure the effectiveness of a newly-designed oculomotor training program for patients with age-related macular degeneration.

Condition Intervention
Age Related Maculopathy Retinal Degeneration Procedure: Eccentric Viewing Training for Reading

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: Double
Official Title: Measuring Reading Rehabilitation Outcomes

Resource links provided by NLM:

Further study details as provided by VA Office of Research and Development:

Primary Outcome Measures:
  • Participants will be given the following assessment tests at 4 different times during the assessment (at baseline, after 6 weeks, after 12 weeks, and after 18 weeks): eye tracking measures, daily performance measures and reading measures.

Estimated Enrollment: 90
Study Start Date: August 2005
Study Completion Date: May 2008
  Show Detailed Description


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with a diagnosis of AMD
  • An established preferred retinal locus
  • Visual acuity of less than or equal to 20/70 and greater than or equal to 20/400 (in the better eye)

Exclusion Criteria:

  • Those with other major ophthalmologic and neurologic disease; choroidal neovascularization ("wet" AMD); moderate to severe media opacities; and cognitive impairment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00125632

United States, Illinois
Jesse Brown VA Medical Center
Chicago, Illinois, United States, 60612
Sponsors and Collaborators
VA Office of Research and Development
Principal Investigator: Janet P Szlyk, Ph.D. Research & Development Service 151, Jesse Brown VA Medical Center
  More Information

Additional Information:
Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00125632     History of Changes
Other Study ID Numbers: O3877R
Study First Received: July 28, 2005
Last Updated: February 3, 2009

Keywords provided by VA Office of Research and Development:
Treatment Outcomes
Low vision

Additional relevant MeSH terms:
Retinal Degeneration
Retinal Diseases
Eye Diseases processed this record on September 20, 2017